Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker,Abcam,AB181598

Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker (ab181598) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P and WB. Abcam's high quality manufacturing and validation processes ensure Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker (ab181598) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker (ab181598) has been confirmed by Western Blot testing in Cytokeratin 7 knockout A549 cells. Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker (ab181598) has 10 independent reviews from customers. Anti-Cytokeratin 7 antibody [EPR17078] - Cytoskeleton Marker (ab181598) specifically detects Cytokeratin 7 (UniProt ID: Q9DCV7; Molecular weight: 51kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR17078 - ab220804 . Antibody clone EPR17078 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, Alexa Fluor ® 594, Alexa Fluor ® 555, HRP, PE ( ab208273 , ab209599 , ab209600 , ab209601 , ab209945 , ab213193 ). Cytokeratin 7 (CK7) is a protein expressed in the epithelial cells of various organs, including the lungs, breast and female reproductive organs. It is used as a diagnostic marker to differentiate between types of carcinomas, such as distinguishing ovarian and gastrointestinal carcinomas and to predict the progression of certain cancers. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .